高级检索
胡美娇, 丁晟, 周江东, 陈运鸿, 李育强, 涂卫国. 肾综合征出血热灭活疫苗(Ⅱ型)在江西省混合型疫区的血清学和流行病学效果观察[J]. 中国公共卫生, 1999, 15(7): 571-573.
引用本文: 胡美娇, 丁晟, 周江东, 陈运鸿, 李育强, 涂卫国. 肾综合征出血热灭活疫苗(Ⅱ型)在江西省混合型疫区的血清学和流行病学效果观察[J]. 中国公共卫生, 1999, 15(7): 571-573.
Hu Meijiao, . Observation on the Safty and Efficay of Inactivated Vaccine(Type Ⅱ) against HFRS[J]. Chinese Journal of Public Health, 1999, 15(7): 571-573.
Citation: Hu Meijiao, . Observation on the Safty and Efficay of Inactivated Vaccine(Type Ⅱ) against HFRS[J]. Chinese Journal of Public Health, 1999, 15(7): 571-573.

肾综合征出血热灭活疫苗(Ⅱ型)在江西省混合型疫区的血清学和流行病学效果观察

Observation on the Safty and Efficay of Inactivated Vaccine(Type Ⅱ) against HFRS

  • 摘要: 为探讨肾综合征出血热灭活疫苗(Ⅱ型)在混合型疫区接种的安全性?免疫效果及免疫(感染)增强反应,于1994年首次在本病高发的江西省奉新县赤岸乡,按0?28?42天的免疫程序,对接种组10个村6140名16~60岁高发人群进行全程免疫,1995年用新制的同型疫苗加强接种一针,经过4年观察,结果(1)?接种后14天用微量细胞病变试验(MCPENT)检测血清中和抗体1∶5阳转率88.24%,GMT12.51,用免疫荧光法检测荧光抗体(IFAT)1∶10阳转率为76.32%GMT13.15。加强后14天1年?2年和3年的中和抗体阳性率分别为100%?47.05%?30.76%和30.76%;GMT分别为14.34?4.08?3.09和3.09。加强后14天?1年?2年和3年IFA抗体阳性率分别为100%?58.82%?53.84%和30.76%,GMT分别为72.19?10.42?8.08和6.52。表明该苗能有效地诱导抗体反应。(2)接种组在加强后2年期间有1人发病,而对照组发病61例,保护率为97.72%。近期中期防病效果好。(3)接种反应轻微,个别人有一过性反应,安全性好。(4)对隐性感染者接种疫苗?对全程免疫后发生的一例病人进行个案调查及对接种人群经过两个流行高峰前后抗体水平变化的观察,均未证实有抗体介导的免疫(感染)增强反应。(5)本次研究首次证实Ⅱ型苗在混合型疫区的防病效果。

     

    Abstract: To study the safty,efficacy and antibody dependenc-enhance-ment(ADE) of inactivated vaccine(TypeⅡ) prepared fromg olden hamster kidne cell(GHKC) against HFRS,6140 healthy people,whose age was 16 to 60 years old,was injected three times on 0,28 day and 42,at 10 villages of Chian township,Fengxin county in 1994,which was made asupplementdery injection in 1995.The study was observed 4 years.The level of antibody in serum,after the third injection,the neutralization antibody(1:50positive rates was 88.24%,its geometric mean titer(GMT) of neutralization antibody was 12.51.IFA(1:10) antibody positive rates was 76.32% and its GMT was 13.15.two weeks,1 years,2 years,3years after the forth injection,the neutralization antibody positive rates were 100%、47.05%、30.76% and 30.76%.Their GMT were 14.34、4.08、3.09 and 3.09 serocnversion of IFA antibody(three times) were 100%、58.82%、53.84% and 30.76% respectively.the GMT of them were 72.19、10.42、8.08 and 6.52these data demonstrated that the vaccine could effectively induce specfic antibody response and the vaccine had a satisfied effect against HFRS in middle-short perioed.The reactions of injection were slight and localreactions only found in few people.It shows that the vaccine was safe.As is shown in the during which we injected to those who had infected,survied the case who completed his vaccination of full doses,observed changed-level of the antibody in serum both fomer and the later which at the Spring and the Autumn peaks of HFRS in 1997;there to be no ADE in these groups.There were 61 cases of HF RS in the control group and 1cases in the test group,making the incidence 178.55/10sup>5,16.29/105,and the protection rate were 97.72%.For the first time,the study revealed that the vaccine type Ⅱ had satisfactory effect in the epidemic area of mix type.

     

/

返回文章
返回